The data presented here shows that treatment of HO-2 null mice with L-4F rescues the key markers of metabolic syndrome via an increase in HO-1 and adiponectin through a signaling mechanism involving the LKB1/AMPK signaling pathway (Figure 5). The gene discussed is HMOX2; the disease is metabolic syndrome.